Randomized Clinical Trial of Efficacy and Safety of a Single 2‐mg Intravenous Dose of Hydromorphone Versus Usual Care in the Management of Acute Pain

Objectives The objective was to test the efficacy and safety of 2 mg of intravenous (IV) hydromorphone (Dilaudid) against “usual care” in emergency department (ED) patients with acute severe pain. Methods This was a randomized clinical trial. Patients allocated to 2 mg of IV hydromorphone received t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Academic emergency medicine 2013-02, Vol.20 (2), p.185-192
Hauptverfasser: Chang, Andrew K., Bijur, Polly E., Lupow, Jason B., John Gallagher, E., Bird, Steven
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!